Small-Molecule Inhibitors Targeting the Canonical WNT Signaling Pathway for the Treatment of Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Small-Molecule Inhibitors Targeting the Canonical WNT Signaling Pathway for the Treatment of Cancer
Authors
Keywords
-
Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 64, Issue 8, Pages 4257-4288
Publisher
American Chemical Society (ACS)
Online
2021-04-07
DOI
10.1021/acs.jmedchem.0c01799
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Porcupine inhibitors: Novel and emerging anti-cancer therapeutics targeting the Wnt signaling pathway
- (2021) Karmani Shah et al. PHARMACOLOGICAL RESEARCH
- Antiepileptic Drug Carbamazepine Binds to a Novel Pocket on the Wnt Receptor Frizzled-8
- (2020) Yuguang Zhao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design and Discovery of an Orally Efficacious Spiroindolinone-Based Tankyrase Inhibitor for the Treatment of Colon Cancer
- (2020) Fumiyuki Shirai et al. JOURNAL OF MEDICINAL CHEMISTRY
- Lorecivivint, a Novel Intra‐articular CLK/DYRK1A Inhibitor and Wnt Pathway Modulator for Treatment of Knee Osteoarthritis: A Phase 2 Randomized Trial
- (2020) Yusuf Yazici et al. Arthritis & Rheumatology
- Targeting β-Catenin Signaling by Natural Products for Cancer Prevention and Therapy
- (2020) Wen-Kai Yu et al. Frontiers in Pharmacology
- Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome
- (2020) Je-Hwan Lee et al. Blood Advances
- WNT/β-catenin pathway activation correlates with immune exclusion across human cancers
- (2019) Jason J. Luke et al. CLINICAL CANCER RESEARCH
- Modulating Wnt signaling at the root: Porcupine and Wnt acylation
- (2019) Viviana I. Torres et al. PHARMACOLOGY & THERAPEUTICS
- Optimization of Peptidomimetics as Selective Inhibitors for the β-Catenin/T-Cell Factor Protein–Protein Interaction
- (2019) Zhen Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Novel Spiroindoline Derivatives as Selective Tankyrase Inhibitors
- (2019) Fumiyuki Shirai et al. JOURNAL OF MEDICINAL CHEMISTRY
- N6-methylation of adenosine (m6A) of FZD10 mRNA contributes to PARP inhibitor resistance
- (2019) Takeshi Fukumoto et al. CANCER RESEARCH
- Crystal structure of a mammalian Wnt–frizzled complex
- (2019) Hidenori Hirai et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Inhibition of β-catenin/B cell lymphoma 9 protein−protein interaction using α-helix–mimicking sulfono-γ-AApeptide inhibitors
- (2019) Peng Sang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pharmacological inhibition of β-catenin/BCL9 interaction overcomes resistance to immune checkpoint blockades by modulating Treg cells
- (2019) M. Feng et al. Science Advances
- Chemical Genetics Reveals a Role of dCTP Pyrophosphatase 1 in Wnt Signaling
- (2019) Alexandra Friese et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- A decade of clinical development of PARP inhibitors in perspective
- (2019) J Mateo et al. ANNALS OF ONCOLOGY
- Non-canonical Wnt signaling regulates junctional mechanocoupling during angiogenic collective cell migration
- (2019) Joana R Carvalho et al. eLife
- The small molecule WNT/β-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway
- (2019) Sahyun Pak et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Discovery and Optimization of 2-Arylquinazolin-4-ones into a Potent and Selective Tankyrase Inhibitor Modulating Wnt Pathway Activity
- (2019) Hans-Peter Buchstaller et al. JOURNAL OF MEDICINAL CHEMISTRY
- Wnt signaling and drug resistance in cancer
- (2019) Zheng Zhong et al. MOLECULAR PHARMACOLOGY
- Pyrazole-4-Carboxamide (YW2065): A Therapeutic Candidate for Colorectal Cancer via Dual Activities of Wnt/β-Catenin Signaling Inhibition and AMP-Activated Protein Kinase (AMPK) Activation
- (2019) Wei Yang et al. JOURNAL OF MEDICINAL CHEMISTRY
- An Underlying Mechanism of Dual Wnt Inhibition and AMPK Activation: Mitochondrial Uncouplers Masquerading as Wnt Inhibitors
- (2019) Wen Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeted disruption of the BCL9/β-catenin interaction by endosomal-escapable nanoparticles functionalized with an E-cadherin-derived peptide
- (2019) Guang Yang et al. NANOTECHNOLOGY
- IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft
- (2018) Sara R. Martins-Neves et al. CANCER LETTERS
- Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors
- (2018) Nithya Krishnamurthy et al. CANCER TREATMENT REVIEWS
- Paracrine Wnt5a-β-Catenin Signaling Triggers a Metabolic Program that Drives Dendritic Cell Tolerization
- (2018) Fei Zhao et al. IMMUNITY
- Novel Ligustrazine-Based Analogs of Piperlongumine Potently Suppress Proliferation and Metastasis of Colorectal Cancer Cells in Vitro and in Vivo
- (2018) Yu Zou et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Based Optimization of Small-Molecule Inhibitors for the β-Catenin/B-Cell Lymphoma 9 Protein–Protein Interaction
- (2018) Min Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Is β-Catenin a Druggable Target for Cancer Therapy?
- (2018) Can Cui et al. TRENDS IN BIOCHEMICAL SCIENCES
- Non-canonical Wnt signaling regulates neural stem cell quiescence during homeostasis and after demyelination
- (2018) Manideep Chavali et al. Nature Communications
- Wnt signaling in human and mouse breast cancer: Focusing on Wnt ligands, receptors and antagonists
- (2018) Ping Yin et al. CANCER SCIENCE
- RK-287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model
- (2018) Anna Mizutani et al. CANCER SCIENCE
- Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts
- (2018) Eric A. Wold et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Potent Disheveled/Dvl Inhibitors Using Virtual Screening Optimized With NMR-Based Docking Performance Index
- (2018) Kiminori Hori et al. Frontiers in Pharmacology
- Proteolysis Targeting Chimera (PROTAC): A Paradigm-Shifting Approach in Small Molecule Drug Discovery
- (2018) Pingyuan Wang et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Drug repurposing: progress, challenges and recommendations
- (2018) Sudeep Pushpakom et al. NATURE REVIEWS DRUG DISCOVERY
- Design of Peptoid-peptide Macrocycles to Inhibit the β-catenin TCF Interaction in Prostate Cancer
- (2018) Jeffrey A. Schneider et al. Nature Communications
- CDK8 as a therapeutic target for cancers and recent developments in discovery of CDK8 inhibitors
- (2018) Meiyang Xi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of tankyrase by a novel small molecule significantly attenuates prostate cancer cell proliferation
- (2018) Honglin Cheng et al. CANCER LETTERS
- The emergence of TNIK as a therapeutic target for colorectal cancer
- (2017) Mari Masuda et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Highly Potent and Isoform Selective Dual Site Binding Tankyrase/Wnt Signaling Inhibitors That Increase Cellular Glucose Uptake and Have Antiproliferative Activity
- (2017) Amit Nathubhai et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a Highly Selective Tankyrase Inhibitor Displaying Growth Inhibition Effects against a Diverse Range of Tumor Derived Cell Lines
- (2017) Douglas W. Thomson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Scaffold Hopping and Optimization of Maleimide Based Porcupine Inhibitors
- (2017) Soo Yei Ho et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a Novel Series of Tankyrase Inhibitors by a Hybridization Approach
- (2017) Upendra Rao Anumala et al. JOURNAL OF MEDICINAL CHEMISTRY
- Macrocyclized Extended Peptides: Inhibiting the Substrate-Recognition Domain of Tankyrase
- (2017) Wenshu Xu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt/β-catenin Signaling
- (2017) Georg Emons et al. MOLECULAR CANCER RESEARCH
- Small molecule promotes β-catenin citrullination and inhibits Wnt signaling in cancer
- (2017) Yi Qu et al. Nature Chemical Biology
- Differential abundance of CK1α provides selectivity for pharmacological CK1α activators to target WNT-dependent tumors
- (2017) Bin Li et al. Science Signaling
- Differential abundance of CK1α provides selectivity for pharmacological CK1α activators to target WNT-dependent tumors
- (2017) Bin Li et al. Science Signaling
- Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial
- (2017) Kiminori Kimura et al. EBioMedicine
- Design, synthesis, and evaluation of novel porcupine inhibitors featuring a fused 3-ring system based on the ‘reversed’ amide scaffold
- (2016) Zhixiang Xu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Discovery of potent and selective CDK8 inhibitors from an HSP90 pharmacophore
- (2016) Kai Schiemann et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- AZ1366: An Inhibitor of Tankyrase and the Canonical Wnt Pathway that Limits the Persistence of Non–Small Cell Lung Cancer Cells Following EGFR Inhibition
- (2016) Hannah A. Scarborough et al. CLINICAL CANCER RESEARCH
- The Wnt signaling pathway in cancer
- (2016) Yann Duchartre et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Design, synthesis, and evaluation of potent Wnt signaling inhibitors featuring a fused 3-ring system
- (2016) Zhixiang Xu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Based Optimization of Potent, Selective, and Orally Bioavailable CDK8 Inhibitors Discovered by High-Throughput Screening
- (2016) Paul Czodrowski et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors
- (2016) Ann-Gerd Thorsell et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Potent, Selective, and Orally Bioavailable Small-Molecule Modulators of the Mediator Complex-Associated Kinases CDK8 and CDK19
- (2016) Aurélie Mallinger et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Discovery and Characterization of K-756, a Novel Wnt/β-Catenin Pathway Inhibitor Targeting Tankyrase
- (2016) Ryoko Okada-Iwasaki et al. MOLECULAR CANCER THERAPEUTICS
- Wnt signaling in cancer
- (2016) T Zhan et al. ONCOGENE
- Discovery of Pyridinyl Acetamide Derivatives as Potent, Selective, and Orally Bioavailable Porcupine Inhibitors
- (2016) Dai Cheng et al. ACS Medicinal Chemistry Letters
- 2,8-Disubstituted-1,6-Naphthyridines and 4,6-Disubstituted-Isoquinolines with Potent, Selective Affinity for CDK8/19
- (2016) Aurélie Mallinger et al. ACS Medicinal Chemistry Letters
- Structure-Based Design of 1,4-Dibenzoylpiperazines as β-Catenin/B-Cell Lymphoma 9 Protein–Protein Interaction Inhibitors
- (2016) John A. Wisniewski et al. ACS Medicinal Chemistry Letters
- Potent and Selective CK2 Kinase Inhibitors with Effects on Wnt Pathway Signaling in Vivo
- (2016) James E. Dowling et al. ACS Medicinal Chemistry Letters
- TNIK inhibition abrogates colorectal cancer stemness
- (2016) Mari Masuda et al. Nature Communications
- CWP232228 targets liver cancer stem cells through Wnt/β‑catenin signaling: a novel therapeutic approach for liver cancer treatment
- (2016) Ji‑Young Kim et al. Oncotarget
- Exploration of the linkage elements of porcupine antagonists led to potent Wnt signaling pathway inhibitors
- (2015) Yan Dong et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Structure-based design, synthesis and evaluation in vitro of arylnaphthyridinones, arylpyridopyrimidinones and their tetrahydro derivatives as inhibitors of the tankyrases
- (2015) Katerina Kumpan et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Exploration of the nicotinamide-binding site of the tankyrases, identifying 3-arylisoquinolin-1-ones as potent and selective inhibitors in vitro
- (2015) Helen A. Paine et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Wnt/ -Catenin Small-Molecule Inhibitor CWP232228 Preferentially Inhibits the Growth of Breast Cancer Stem-like Cells
- (2015) G.-B. Jang et al. CANCER RESEARCH
- A Small-Molecule Antagonist of the -Catenin/TCF4 Interaction Blocks the Self-Renewal of Cancer Stem Cells and Suppresses Tumorigenesis
- (2015) L. Fang et al. CANCER RESEARCH
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- Tankyrase Inhibition Blocks Wnt/ -Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer
- (2015) O. Arques et al. CLINICAL CANCER RESEARCH
- Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer
- (2015) Lele Song et al. Clinical Colorectal Cancer
- Small-molecule inhibitors of Wnt signaling pathway: towards novel anticancer therapeutics
- (2015) Shilong Zheng et al. Future Medicinal Chemistry
- Discovery and Optimization of a Porcupine Inhibitor
- (2015) Athisayamani Jeyaraj Duraiswamy et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Selective Small-Molecule Inhibitors for the β-Catenin/T-Cell Factor Protein–Protein Interaction through the Optimization of the Acyl Hydrazone Moiety
- (2015) J. Leon Catrow et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Potent, Orally Bioavailable, Small-Molecule Inhibitors of WNT Signaling from a Cell-Based Pathway Screen
- (2015) Aurélie Mallinger et al. JOURNAL OF MEDICINAL CHEMISTRY
- Rational Design of Selective Small-Molecule Inhibitors for β-Catenin/B-Cell Lymphoma 9 Protein–Protein Interactions
- (2015) Logan R. Hoggard et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- Transcriptional plasticity promotes primary and acquired resistance to BET inhibition
- (2015) Philipp Rathert et al. NATURE
- BET inhibitor resistance emerges from leukaemia stem cells
- (2015) Chun Yew Fong et al. NATURE
- Wnt addiction of genetically defined cancers reversed by PORCN inhibition
- (2015) B Madan et al. ONCOGENE
- Targeting the WNT Signaling Pathway in Cancer Therapeutics
- (2015) D. Tai et al. ONCOLOGIST
- Therapeutic targeting of casein kinase 1δ in breast cancer
- (2015) Laura H. Rosenberg et al. Science Translational Medicine
- Pyrimidinone Nicotinamide Mimetics as Selective Tankyrase and Wnt Pathway Inhibitors Suitable for in Vivo Pharmacology
- (2015) Jeffrey W. Johannes et al. ACS Medicinal Chemistry Letters
- Fragment-Based Drug Design of Novel Pyranopyridones as Cell Active and Orally Bioavailable Tankyrase Inhibitors
- (2015) Javier de Vicente et al. ACS Medicinal Chemistry Letters
- Skp2–MacroH2A1–CDK8 axis orchestrates G2/M transition and tumorigenesis
- (2015) Dazhi Xu et al. Nature Communications
- Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy
- (2015) A. Holtzhausen et al. Cancer Immunology Research
- Inhibition of Cyclic Adenosine Monophosphate (cAMP)-response Element-binding Protein (CREB)-binding Protein (CBP)/β-Catenin Reduces Liver Fibrosis in Mice
- (2015) Yosuke Osawa et al. EBioMedicine
- Drug Discovery Approaches to Target Wnt Signaling in Cancer Stem Cells
- (2015) Oncotarget
- GSK3β and β-Catenin Modulate Radiation Cytotoxicity in Pancreatic Cancer
- (2015) Richard L. Watson et al. NEOPLASIA
- Identification and Characterization of a Novel Small-Molecule Inhibitor of β-Catenin Signaling
- (2014) Evan R. Delgado et al. AMERICAN JOURNAL OF PATHOLOGY
- Safely targeting cancer stem cells via selective catenin coactivator antagonism
- (2014) Heinz-Josef Lenz et al. CANCER SCIENCE
- Wnt-induced transcriptional activation is exclusively mediated by TCF/LEF
- (2014) Jurian Schuijers et al. EMBO JOURNAL
- Disulfide Bond Requirements for Active Wnt Ligands
- (2014) Bryan T. MacDonald et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Synthesis and Biological Evaluation of Furanoallocolchicinoids
- (2014) Yuliya V. Voitovich et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, Crystallographic Studies, and Preliminary Biological Appraisal of New Substituted Triazolo[4,3-b]pyridazin-8-amine Derivatives as Tankyrase Inhibitors
- (2014) Paride Liscio et al. JOURNAL OF MEDICINAL CHEMISTRY
- The CK1 Family: Contribution to Cellular Stress Response and Its Role in Carcinogenesis
- (2014) Uwe Knippschild et al. Frontiers in Oncology
- Targeting the Tcf4 G13ANDE17 Binding Site To Selectively Disrupt β-Catenin/T-Cell Factor Protein–Protein Interactions
- (2013) Zheng Huang et al. ACS Chemical Biology
- Development of highly selective casein kinase 1δ/1ε (CK1δ/ε) inhibitors with potent antiproliferative properties
- (2013) Mathieu Bibian et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells
- (2013) Yuan Gao et al. CANCER LETTERS
- A Novel Tankyrase Small-Molecule Inhibitor Suppresses APC Mutation-Driven Colorectal Tumor Growth
- (2013) T. Lau et al. CANCER RESEARCH
- WNT10B/β-catenin signalling induces HMGA2 and proliferation in metastatic triple-negative breast cancer
- (2013) Peter Wend et al. EMBO Molecular Medicine
- Development of Novel Dual Binders as Potent, Selective, and Orally Bioavailable Tankyrase Inhibitors
- (2013) Zihao Hua et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure–Efficiency Relationship of [1,2,4]Triazol-3-ylamines as Novel Nicotinamide Isosteres that Inhibit Tankyrases
- (2013) Michael D. Shultz et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fragment-Based Ligand Design of Novel Potent Inhibitors of Tankyrases
- (2013) E. Andreas Larsson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Novel, Induced-Pocket Binding Oxazolidinones as Potent, Selective, and Orally Bioavailable Tankyrase Inhibitors
- (2013) Howard Bregman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of NVP-TNKS656: The Use of Structure–Efficiency Relationships To Generate a Highly Potent, Selective, and Orally Active Tankyrase Inhibitor
- (2013) Michael D. Shultz et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a Class of Novel Tankyrase Inhibitors that Bind to Both the Nicotinamide Pocket and the Induced Pocket
- (2013) Howard Bregman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Tankyrase Inhibiting Flavones with Increased Potency and Isoenzyme Selectivity
- (2013) Mohit Narwal et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structural Basis and SAR for G007-LK, a Lead Stage 1,2,4-Triazole Based Specific Tankyrase 1/2 Inhibitor
- (2013) Andrew Voronkov et al. JOURNAL OF MEDICINAL CHEMISTRY
- Screening and Structural Analysis of Flavones Inhibiting Tankyrases
- (2013) Mohit Narwal et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Development of Highly Potent Inhibitors for Porcupine
- (2013) Xiaolei Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells
- (2013) A. De Robertis et al. MOLECULAR CANCER THERAPEUTICS
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
- (2013) J. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural Studies of Wnts and Identification of an LRP6 Binding Site
- (2013) Matthew Ling-Hon Chu et al. STRUCTURE
- Structure-Based Design of 2-Aminopyridine Oxazolidinones as Potent and Selective Tankyrase Inhibitors
- (2013) Hongbing Huang et al. ACS Medicinal Chemistry Letters
- Design and Discovery of 2-Arylquinazolin-4-ones as Potent and Selective Inhibitors of Tankyrases
- (2013) Amit Nathubhai et al. ACS Medicinal Chemistry Letters
- Selective Small Molecule Targeting β-Catenin Function Discovered by In Vivo Chemical Genetic Screen
- (2013) Jijun Hao et al. Cell Reports
- Rational Design of Small-Molecule Inhibitors for β-Catenin/T-Cell Factor Protein–Protein Interactions by Bioisostere Replacement
- (2012) Binxun Yu et al. ACS Chemical Biology
- A Novel Tankyrase Inhibitor Decreases Canonical Wnt Signaling in Colon Carcinoma Cells and Reduces Tumor Growth in Conditional APC Mutant Mice
- (2012) J. Waaler et al. CANCER RESEARCH
- Pharmacological Inhibition of the Wnt Acyltransferase PORCN Prevents Growth of WNT-Driven Mammary Cancer
- (2012) K. D. Proffitt et al. CANCER RESEARCH
- Wnt/β-Catenin Signaling and Disease
- (2012) Hans Clevers et al. CELL
- Precise Regulation of Porcupine Activity Is Required for Physiological Wnt Signaling
- (2012) Kyle D. Proffitt et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Diverse Chemical Scaffolds Support Direct Inhibition of the Membrane-boundO-Acyltransferase Porcupine
- (2012) Michael E. Dodge et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- [1,2,4]Triazol-3-ylsulfanylmethyl)-3-phenyl-[1,2,4]oxadiazoles: Antagonists of the Wnt Pathway That Inhibit Tankyrases 1 and 2 via Novel Adenosine Pocket Binding
- (2012) Michael D. Shultz et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structural Basis of Selective Inhibition of Human Tankyrases
- (2012) Mohit Narwal et al. JOURNAL OF MEDICINAL CHEMISTRY
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- Tankyrase-targeted therapeutics: expanding opportunities in the PARP family
- (2012) Jenna L. Riffell et al. NATURE REVIEWS DRUG DISCOVERY
- In vivo and in vitro models for the therapeutic targeting of Wnt signaling using a Tet-OΔN89β-catenin system
- (2012) T Jardé et al. ONCOGENE
- WIKI4, a Novel Inhibitor of Tankyrase and Wnt/ß-Catenin Signaling
- (2012) Richard G. James et al. PLoS One
- Inhibition of oncogenic Wnt signaling through direct targeting of -catenin
- (2012) T. N. Grossmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural Basis of Wnt Recognition by Frizzled
- (2012) C. Y. Janda et al. SCIENCE
- Targeted Disruption of the BCL9/ -Catenin Complex Inhibits Oncogenic Wnt Signaling
- (2012) K. Takada et al. Science Translational Medicine
- WNT secretion and signalling in human disease
- (2012) Patrick Herr et al. TRENDS IN MOLECULAR MEDICINE
- Potent and Selective Inhibitors of CK2 Kinase Identified through Structure-Guided Hybridization
- (2012) James E. Dowling et al. ACS Medicinal Chemistry Letters
- Molecular Genetics of Colorectal Cancer
- (2011) Eric R. Fearon Annual Review of Pathology-Mechanisms of Disease
- Novel Synthetic Antagonists of Canonical Wnt Signaling Inhibit Colorectal Cancer Cell Growth
- (2011) J. Waaler et al. CANCER RESEARCH
- Structural Basis and Sequence Rules for Substrate Recognition by Tankyrase Explain the Basis for Cherubism Disease
- (2011) Sebastian Guettler et al. CELL
- Design of Triazole-Stapled BCL9 α-Helical Peptides to Target the β-Catenin/B-Cell CLL/lymphoma 9 (BCL9) Protein–Protein Interaction
- (2011) Steven A. Kawamoto et al. JOURNAL OF MEDICINAL CHEMISTRY
- IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1δ/ɛ and Wnt/β-catenin independent inhibition of mitotic spindle formation
- (2011) J K Cheong et al. ONCOGENE
- FZD7 has a critical role in cell proliferation in triple negative breast cancer
- (2011) L Yang et al. ONCOGENE
- An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway
- (2011) F. C. Gonsalves et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A novel yeast cell-based screen identifies flavone as a tankyrase inhibitor
- (2010) Yoko Yashiroda et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Traf2- and Nck-Interacting Kinase Is Essential for Wnt Signaling and Colorectal Cancer Growth
- (2010) Miki Shitashige et al. CANCER RESEARCH
- Epigenetic gene silencing in the Wnt pathway in breast cancer
- (2010) George J. Klarmann et al. Epigenetics
- Structural Basis for the Interaction between Tankyrase-2 and a Potent Wnt-Signaling Inhibitor
- (2010) Tobias Karlberg et al. JOURNAL OF MEDICINAL CHEMISTRY
- Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α
- (2010) Curtis A Thorne et al. Nature Chemical Biology
- LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy
- (2010) C.-C. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Toward a unified nomenclature for mammalian ADP-ribosyltransferases
- (2010) Michael O. Hottiger et al. TRENDS IN BIOCHEMICAL SCIENCES
- Identification of tripeptides recognized by the PDZ domain of Dishevelled
- (2009) Ho-Jin Lee et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
- (2009) Bryan T. MacDonald et al. DEVELOPMENTAL CELL
- Discovery and Characterization of a Small Molecule Inhibitor of the PDZ Domain of Dishevelled
- (2009) David Grandy et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
- (2009) Shih-Min A. Huang et al. NATURE
- Small molecule–mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer
- (2009) Baozhi Chen et al. Nature Chemical Biology
- Proximal events in Wnt signal transduction
- (2009) Stephane Angers et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Activated Wnt/ss-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model
- (2009) A. J. Chien et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Wnt Signaling in Development, Disease and Translational Medicine
- (2008) Gary Coombs et al. CURRENT DRUG TARGETS
- Paracrine Wingless signalling controls self-renewal of Drosophila intestinal stem cells
- (2008) Guonan Lin et al. NATURE
- E2F1 represses β-catenin transcription and is antagonized by both pRB and CDK8
- (2008) Erick J. Morris et al. NATURE
- Suppression of PPN/MG61 attenuates Wnt/β-catenin signaling pathway and induces apoptosis in human lung cancer
- (2008) Z Chen et al. ONCOGENE
- Crystal Structure of a Full-Length β-Catenin
- (2008) Yi Xing et al. STRUCTURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More